We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03263039
Brief Title: Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab (RESPONDER)

First Submitted : August 18, 2017
First Submitted that Met QC Criteria : August 23, 2017
First Posted : August 28, 2017

Last Update Submitted that Met QC Criteria : August 19, 2021
Last Update Posted : August 20, 2021